BlackRock’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.9M Buy
12,142,596
+9,069,823
+295% +$11.2M ﹤0.01% 3133
2025
Q1
$3.38M Buy
3,072,773
+43,564
+1% +$47.9K ﹤0.01% 3756
2024
Q4
$2.74M Buy
3,029,209
+223,567
+8% +$202K ﹤0.01% 3897
2024
Q3
$2.77M Sell
2,805,642
-5,865
-0.2% -$5.79K ﹤0.01% 3852
2024
Q2
$2.53M Sell
2,811,507
-277,819
-9% -$250K ﹤0.01% 3850
2024
Q1
$3.65M Sell
3,089,326
-289,320
-9% -$341K ﹤0.01% 3749
2023
Q4
$3.08M Sell
3,378,646
-1,088,007
-24% -$993K ﹤0.01% 3805
2023
Q3
$3.72M Buy
4,466,653
+2,554,648
+134% +$2.13M ﹤0.01% 3724
2023
Q2
$2.29M Sell
1,912,005
-2,881,674
-60% -$3.46M ﹤0.01% 3917
2023
Q1
$6.04M Sell
4,793,679
-619,344
-11% -$780K ﹤0.01% 3476
2022
Q4
$11.7M Sell
5,413,023
-95,154
-2% -$206K ﹤0.01% 3259
2022
Q3
$66M Buy
5,508,177
+342,213
+7% +$4.1M ﹤0.01% 2226
2022
Q2
$43.2M Sell
5,165,964
-163,167
-3% -$1.37M ﹤0.01% 2550
2022
Q1
$46.3M Sell
5,329,131
-100,555
-2% -$873K ﹤0.01% 2596
2021
Q4
$61.4M Buy
5,429,686
+66,816
+1% +$756K ﹤0.01% 2490
2021
Q3
$67.4M Sell
5,362,870
-52,935
-1% -$665K ﹤0.01% 2432
2021
Q2
$44M Buy
5,415,805
+50,456
+0.9% +$410K ﹤0.01% 2748
2021
Q1
$49.6M Buy
5,365,349
+663,314
+14% +$6.14M ﹤0.01% 2577
2020
Q4
$45.5M Buy
4,702,035
+62,411
+1% +$604K ﹤0.01% 2488
2020
Q3
$57.6M Buy
4,639,624
+344,508
+8% +$4.28M ﹤0.01% 2168
2020
Q2
$55.8M Buy
4,295,116
+788,180
+22% +$10.2M ﹤0.01% 2162
2020
Q1
$35.6M Sell
3,506,936
-39,584
-1% -$402K ﹤0.01% 2251
2019
Q4
$55.4M Buy
3,546,520
+743,721
+27% +$11.6M ﹤0.01% 2282
2019
Q3
$47.1M Buy
2,802,799
+1,507,575
+116% +$25.3M ﹤0.01% 2307
2019
Q2
$28.7M Buy
1,295,224
+500,944
+63% +$11.1M ﹤0.01% 2621
2019
Q1
$17.2M Buy
+794,280
New +$17.2M ﹤0.01% 2810